2321 - 2330 of 6324 Results
Title
Year
-
OPENTitle: Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease PsychosisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1389End Page: 1396Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202047Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202047?id=journal-of-parkinsons-disease%2Fjpd202047Citation Count: 14
-
OPENTitle: A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and DesignJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1195End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202019Best OA location URL: https://escholarship.org/uc/item/9nz468vjCitation Count: 10
-
OPENTitle: Clinical Trial Highlights – Infusion TherapiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 5End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-199005Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd199005?id=journal-of-parkinsons-disease%2Fjpd199005Citation Count: 9
-
OPENTitle: Perceptions of Compensation Strategies for Gait Impairments in Parkinson’s Disease: A Survey Among 320 Healthcare ProfessionalsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1775End Page: 1778Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202176Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202176?id=journal-of-parkinsons-disease%2Fjpd202176Citation Count: 13
-
OPENTitle: Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1011End Page: 1021Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191896Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8034435Citation Count: 12
-
OPENTitle: Clinical Progression of Parkinson’s Disease: Insights from the NINDS Common Data ElementsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1075End Page: 1085Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201932Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8177750Citation Count: 25
-
OPENTitle: Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formationJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-024-06751-zBest OA location URL: https://www.nature.com/articles/s42003-024-06751-z.pdfCitation Count: 7
- Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies2024OPENTitle: Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologiesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 385Issue #: 6711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm6131Citation Count: 76
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19